Group 1 - The chairman and vice president of Zhuojin Co., Ltd. have been released on bail pending trial due to violations related to information disclosure, which are linked to a previous administrative penalty by the China Securities Regulatory Commission (CSRC) [2][5] - Zhuojin Co., Ltd. stated that the information disclosure violations do not involve circumstances that would lead to mandatory delisting, and the company continues to operate normally [4] - The company was fined 3 million CNY for the violations, with the chairman and other executives also receiving individual fines [6] Group 2 - Zhuojin Co., Ltd. reported a significant decline in revenue, with a total operating income of 71.6 million CNY for the first three quarters of 2023, a decrease of 61.57% year-on-year [6] - The net loss attributable to the parent company for the same period was 52.16 million CNY, indicating an expanded loss compared to previous periods [6] - The company’s main business includes "comprehensive environmental governance services" and "environmental product sales and services," placing it within the ecological protection and environmental governance industry [6]

【导读】卓锦股份董事长及副总被取保候审 中国基金报记者 李智 12月15日， 卓锦股份 发布公告称， 控股股东、实际控制人、董事长兼总经理卓未龙与董事兼副总经理陈奉 连 被取保候审 。 董事长及副总被取保候审 12月15日，卓锦股份发布公告称，公司控股股东、实际控制人、董事长兼总经理卓未龙与公司董事兼副总经理陈奉连收到杭州市公安局出 具的《取保候审决定书》，所涉及违规披露事项与公司2023年5月被中国证券监督管理委员会浙江监管局行政处罚系同一事项。根据《中 华人民共和国刑事诉讼法》第六十七条的规定，杭州市公安局决定对其取保候审，期限自2025年12月12日起算。 卓锦股份 表示， 根据《上海证券交易所股票上市规则》的相关规定，公司上述信息披露违法行为不涉及重大信息披露违法强制退市情形。 目前，卓未龙与陈奉连能够正常履职，公司日常经营运作正常，各项工作有序开展。公司将持续关注上述事项的进展情况，并严格按照有 关 法律法规 的规定和要求，及时履行信息披露义务。 因 2021年年报存在虚假记载 卓锦股份 高管曾被处罚 2023年2月3日，卓锦股份因涉嫌信息披露违法违规，被中国证监会立案调查。 5月19日，卓锦股份收 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 证监会一份立案告知书，让*ST沪科（维权）的信息披露问题成为市场焦点，而在这份通知背后，一系 列法律追索权的大门已经为受损股民打开。 一、涉信息披露违法违规 2025年12月12日，上海宽频科技股份有限公司（证券简称：*ST沪科）收到中国证监会下发的《立案告 知书》。 因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》等法律法规，中国证监会已正式决定对 公司立案调查。 根据历史案例，上市公司一旦被证监会立案调查，最终被认定为信息披露违法违规并受到处罚的可能性 较大，立案调查期间，公司将面临投资者的集体诉讼。 至于违规细节，公告中并未披露，具体还需等待监管调查。上海沪紫律师事务所刘鹏律师表示，暂定于 2025年12月12日（含当日）之前买入，并在2025年12月13日之后卖出或仍持有而亏损的即可参与维权， 挽回损失。（*ST沪科维权入口） 随着 ...

Core Viewpoint - *ST HuKe has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into alleged violations of information disclosure laws, leading to a formal case being opened against the company [1][4]. Financial Issues - As of November 28, 2025, *ST HuKe reported that its former controlling shareholder, Nanjing Sweet Group Co., Ltd., and its affiliates had illegally occupied company funds amounting to RMB 348,612,206.20, which represents 921.63% of the latest audited net assets [2][4]. - The financial performance for the first three quarters of 2025 showed that *ST HuKe achieved approximately RMB 5.44 million in revenue, a year-on-year decline of 63.7%, while the net profit attributable to shareholders was about RMB 1.06 million, reflecting a significant increase of 448.84% [2][4]. - The company has reported continuous losses for 2023 and 2024, with net profits of -RMB 22.01 million and -RMB 5.68 million, respectively [2][4]. Legal Implications - Legal expert Zhang Yun indicated that investors who purchased *ST HuKe shares before December 12, 2025, and sold or held them after December 13, 2025, may be eligible for compensation due to the ongoing investigation [3][5].

Core Viewpoint - Guangdong Zijing Information Storage Technology Co., Ltd. has been forced to delist due to major violations, with significant legal consequences for its executives [1][11]. Legal Consequences - The company was fined 37 million RMB for fraudulently issuing securities [4][14]. - The actual controller Zheng Mu received a combined prison sentence of 7 years and 6 months for multiple offenses, including fraud and failure to disclose important information [4][14]. - Other executives, including Luo Tiewei and Li Yanxia, received varying prison sentences, with the highest being 7 years for Luo Tiewei [5][15]. Company Background - Zijing Storage was established on April 15, 2010, and primarily engaged in the research, manufacturing, and sales of storage devices [6][18]. - The company was listed on the National Equities Exchange and Quotations (NEEQ) in April 2016 and later on the Sci-Tech Innovation Board in February 2020, raising a total of 1.023 billion RMB [7][19]. Financial Misconduct - From 2017 to 2019, the company engaged in financial fraud, including inflating revenue and profits through false contracts and documents [7][19]. - The inflated profits accounted for 34.83% of total profits in 2017 and 32.25% in 2018, with 42.97% of revenue in the first half of 2019 being fraudulent [8][19]. Performance Decline - After going public, the company's performance deteriorated, with a revenue drop of 6.69% in 2021 and a net loss of 229 million RMB, a decline of 379.85% [8][20]. - The company faced regulatory scrutiny and was investigated for information disclosure violations, leading to its delisting in July 2023 [9][20]. Investor Compensation - The case set a precedent for investor compensation in the Sci-Tech Innovation Board, with intermediary institutions committing 1.275 billion RMB for investor payouts [9][21]. - By June 30, 2023, 97.22% of affected investors had reached settlements, receiving a total of 1.086 billion RMB in compensation [9][21].

Group 1 - The core point of the article is that *ST HuKe has received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws, but the company states that its operations are normal and will not be significantly affected by this matter [1] - As of the first three quarters of 2025, *ST HuKe reported a revenue of 5.44 million yuan, a year-on-year decrease of 63.7%, while the net profit attributable to shareholders increased by 448.84% to 1.06 million yuan [1] Group 2 - On November 28, *ST HuKe disclosed that its former controlling shareholder, Nanjing Sweet Group Co., Ltd., and its affiliates had illegally occupied approximately 349 million yuan of the company's funds, which accounts for 921.63% of the latest audited net assets [2] - The company plans to publicly transfer all debts and other contingent claims against Nanjing Sweet Group and its affiliates due to historical issues, subject to approval from the State-owned Assets Supervision and Administration Commission, the board of directors, and the shareholders' meeting [2] - On December 2, *ST HuKe announced the resignation of its director and board secretary, Yun Feng, due to personal health reasons, and the chairman will temporarily assume the secretary's duties during the vacancy [2]

Core Viewpoint - *ST HuKe is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, which adds to the company's existing delisting risk [2][4]. Group 1: Company Status - As of December 12, *ST HuKe's stock price was 3.81 yuan, with a market capitalization of 1.253 billion yuan, reflecting a decline of 0.26% [4]. - The company has been facing delisting risks since April 30, when its stock was flagged due to negative audited profit totals and revenues below 300 million yuan [6]. - The company reported a significant decline in operating scale, with revenues dropping from 367 million yuan in 2022 to 17 million yuan in 2024 [4][6]. Group 2: Financial Performance - The company is projected to incur continuous losses, with net profits of -22.015 million yuan in 2023 and -5.6828 million yuan in 2024 [4]. - For the first three quarters of 2025, *ST HuKe's revenue was only 5.4403 million yuan, representing a year-on-year decline of 63.70%, with a non-recurring net profit of -237,200 yuan [6]. - The decline in revenue is attributed to decreased income from both chemical and agricultural product trading, as well as increased contract penalties in the agricultural sector [6].

Group 1 - The company Shanghai Broadband Technology Co., Ltd. (*ST HuKe, 600608) has received a notice of investigation from the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [1][3] - The company states that its production and operational activities are currently normal and that the investigation will not have a significant impact on its management [3] - The company is primarily engaged in the trade of agricultural and chemical products, classified under the "F51 Wholesale Industry" according to the CSRC [4] Group 2 - The company's financial performance is concerning, with a reported revenue of 1.04 million yuan in Q3 2025, a year-on-year decrease of 56.95%, and a net profit of 102.71 thousand yuan [4] - For the first three quarters of 2025, the total revenue was only 5.44 million yuan, with a net loss of 240 thousand yuan [4] - As of the end of the reporting period, the total number of shareholders was 11,676, and the company's stock price has fallen for nine consecutive trading days, closing at 3.81 yuan per share [4]

Core Viewpoint - *ST沪科 has received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws, which the company claims will not significantly impact its operations and management [1][2]. Financial Performance - In the first three quarters of the year, *ST沪科 reported revenue of only 5.44 million, a year-on-year decline of 63.7%, while the net profit attributable to shareholders was 1.06 million, showing a significant increase [2]. - The company's revenue dropped sharply from 367 million in 2022 to 17.23 million in 2024, falling below 100 million [2]. - Continuous losses are expected for the years 2023 and 2024, with a risk of delisting if the total profit, net profit, or net profit after excluding non-recurring gains and losses is negative and revenue is below 300 million in 2025 [2]. Management Changes - Following the resignation of Yun Feng, the company’s board secretary and financial officer, the chairman Wang Tianyang is temporarily taking over the secretary duties, while financial manager Yang Xiuxin is acting as the financial officer [3]. - Yun Feng, who was appointed as a director in March 2024 and took on the roles of board secretary and financial officer in November, resigned due to personal health reasons after just over a year in these positions [3]. - Other significant management changes include the resignation of the chairman Zhang Lu in April and independent director Li Zheng in August, both citing personal reasons [3]. Shareholder Issues - The second-largest shareholder, Kunming Industrial Development Investment Co., Ltd., has had all its shares frozen, and the first-largest shareholder's shares are also under freeze [3]. - As of October, the former controlling shareholder, Nanjing Siweit Group Co., Ltd., and its affiliates had illegally occupied 349 million of the company's funds, accounting for 921.63% of the latest audited net assets [4].

Group 1 - *ST Hu Ke announced on December 12, 2025, that it received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws [1][3] - The company stated that its production and operational activities are currently normal and that the investigation will not have a significant impact on its management [3] - The main business of *ST Hu Ke focuses on the trade of agricultural and chemical products, classified under "F51 Wholesale Industry" according to the CSRC [3] Group 2 - For the third quarter, *ST Hu Ke reported a revenue of 1.04 million yuan, a year-on-year decrease of 56.95%, with a net profit attributable to shareholders of 1.0271 million yuan [4] - As of December 12, 2025, *ST Hu Ke's stock price was 3.81 yuan per share, with a total market capitalization of 1.253 billion yuan [4] Group 3 - On the same day, Renfu Pharmaceutical announced it received a notice of administrative penalty from the CSRC for failing to disclose non-operating fund occupation and significant omissions in its annual reports for 2020 and 2022 [7] - Renfu Pharmaceutical's stock will be subject to risk warnings starting December 16, 2025, with a trading limit of 5% on price fluctuations [7][9] - The company, established in 1993, is a leading pharmaceutical enterprise in Hubei Province, focusing on a full industrial chain from intermediates to drug formulations [9] Group 4 - As of December 12, 2025, Renfu Pharmaceutical's stock price was 18.15 yuan per share, with a total market capitalization of 29.625 billion yuan [9]